• Commons Clinic is redefining specialty care with a next-generation model for integrated, physician-led prevention and intervention that meets people where they are
• Its new Wholebody program provides comprehensive diagnostics and direct specialist treatments that unite musculoskeletal, cardiovascular, women’s health, metabolic, orthopedic, GI, chronic pain, and preventive oncology care into one seamless system

LOS ANGELES, June 12, 2025 /PRNewswire/ — Commons Clinic today announced a $26 million Series B financing, bringing its total funding to over $60 million. The round was led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventures, and Commons Clinic physicians. This funding supports the launch of Wholebody by Commons Clinic, a multi-specialty suite connecting all of the organization’s advanced preventative care offerings. Through early detection, tailored prevention, and accountable intervention, Wholebody furthers Common Clinic’s mission to reinvent specialty care.

Wholebody puts Commons Clinic’s team of renowned specialists at the center of early detection and prevention. Its five specialty programs harness advanced diagnostic technologies to thoroughly evaluate essential health indicators like cardiometabolic wellness, musculoskeletal conditions, women’s health, weight management, hormonal balance, gastrointestinal health, chronic pain, and preventive oncology. Each patient program includes up to three specialty consults via Commons Clinic’s national expert network and offers priority placement into its vetted “FastPass” network of primary care partners, ensuring patients experience accelerated, contiguous, and highly accountable care.

Whether identifying the BRCA gene in women prompting prophylactic mastectomy in Commons’ surgery centers, detecting unacceptable coronary plaque levels requiring a PCI procedure, or discovering early-stage cancer markers via the Galeri test and facilitating rapid connection to its oncology expert network, Commons Clinic puts patients on immediate, actionable pathways to specialized care.

“Specialty healthcare too often begins after prevention fails. Patients lack timely access to specialized clinical expertise, leaving conditions to worsen over time before they receive treatment,” said Nick Aubin, co-founder and CEO of Commons Clinic. “Equipped with the industry’s most advanced technologies, we are able to quantify health risk, identify specific conditions, and quickly treat issues across the entire body.”

Inspired by institutions like the Mayo Clinic, Cleveland Clinic, Hospital for Special Surgery, and MD Anderson for their enduring legacy of advancing specialty healthcare, Commons Clinic’s physicians are some of the best minds in specialty medicine. Working at the heart of care delivery and innovation, their efforts are setting a new standard for high-value specialty services while reducing costs. Commons Clinic is expanding its physician-led approach across multiple high-impact specialty domains through the launch of its Wholebody program.

“At Commons Clinic, we’ve built our foundation as a musculoskeletal center-of-excellence that combines advanced surgical treatments with thoughtful conservative care,” said Ben Schwartz, MD, SVP of Care Services at Commons Clinic. “Now, we’re applying that same playbook to the entire body, extending our specialty care model into metabolic, cardiac, cancer, and women’s health. This integrated approach is exactly what people need to solve complex health challenges earlier, smarter, and with more precision.”

Commons has demonstrated success with its care philosophy centered on prevention and early intervention through its musculoskeletal care program, which prevents premature surgeries and accelerates the frontier of advanced,  high-yield surgical techniques and technologies. During the past year alone, Commons’ Dr. Andrew Wassef performed the first ever Mako robotic revision hip replacement, Dr. Hyun Bae published definitive research on the positive efficacy of allogeneic mesenchymal precursor cells for treatment of chronic low back pain, and Dr. Prem Ramkumar was named Associate Editor at the prestigious Journal of Bone & Joint Surgery.

“What sets Commons Clinic apart is its focus on delivering world-class interventional specialty care seamlessly through a vertically integrated model,” said John Loser, Managing Director at Floating Point. “Through its deep expertise in complex ambulatory surgical care and extraordinary concentration of top-tier specialty talent, Commons Clinic is reimagining the future of specialty care and building the Cleveland Clinic of tomorrow.”

Board-certified cardiologist Dr. Jenica Ortega will lead the Wholebody program, with a specific focus on building its cardiac, metabolic, bariatric, and women’s health service lines. Additionally, Brad Hively, the former CEO of The Oncology Institute, recently joined Commons’ board to leverage his 25 years of healthcare experience to advise on specialty value-based care strategy & expansion.

For additional details on Wholebody by Commons Clinic, visit commonsclinic.com/wholebody.

About Commons Clinic
Commons Clinic is pioneering an integrated, specialty-led healthcare platform that seamlessly combines preventive diagnostics with definitive, specialist-driven interventions. Spanning musculoskeletal, cardiovascular, women’s health, metabolic, chronic pain management, preventive oncology, and more. Commons Clinic unifies advanced diagnostics, personalized care pathways, and interventional procedures in a single accountable system. Its vertically integrated model ensures timely decision-making, clearer care navigation, and superior clinical outcomes. For more information, visit commonsclinic.com.

Media Contact:
commonsclinic@hermespr.co

SOURCE Commons Clinic

Copyright © 2025 Cision US Inc.